Congenital CMV-Associated Hearing Loss: Can Brain Imaging Predict Hearing Outcome?
Journal
Ear and hearing
ISSN: 1538-4667
Titre abrégé: Ear Hear
Pays: United States
ID NLM: 8005585
Informations de publication
Date de publication:
Historique:
pubmed:
10
8
2020
medline:
9
7
2021
entrez:
10
8
2020
Statut:
ppublish
Résumé
Congenital cytomegalovirus (cCMV) infection is the leading cause of nonhereditary sensorineural hearing loss in childhood and is also associated with CNS abnormalities. The main objective is to investigate the prognostic value of neonatal cranial ultrasound (cUS) and cranial magnetic resonance imaging (cMRI) in predicting long-term hearing outcome in a large cohort of cCMV-infected symptomatic and asymptomatic patients. Data were prospectively collected from a multicentre Flemish registry of children with cCMV infection born between 2007 and 2016. Neonatal cUS and cMRI scans were examined for lesions related to cCMV infection. Audiometric results at different time points were analyzed. The imaging and audiometric results were linked and diagnostic values of cUS and cMRI were calculated for the different hearing outcomes. We were able to include 411 cCMV patients, of whom 40% was considered symptomatic at birth. Cranial ultrasound abnormalities associated with cCMV infection were found in 76 children (22.2% of the cUS scans), whereas cMRI revealed abnormalities in 74 patients (26.9% of the cMRI scans). A significant relation could be found between the presence of cUS or cMRI abnormalities and hearing loss at baseline and last follow-up. Cranial ultrasound and cMRI findings were not significantly correlated with the development of delayed-onset hearing loss. Specificity and sensitivity of an abnormal cUS to predict hearing loss at final follow-up were 84% and 43%, respectively compared with 78% and 39% for cMRI. Normal cUS and cMRI findings have a negative predictive value of 91% and 92%, respectively, for the development of delayed-onset hearing loss. Neuroimaging evidence of CNS involvement in the neonatal period is associated with the presence of hearing loss in children with a cCMV infection. Imaging abnormalities are not predictive for the development of delayed-onset hearing loss.
Identifiants
pubmed: 32769435
pii: 00003446-202103000-00013
doi: 10.1097/AUD.0000000000000927
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
373-380Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Alarcon A., Martinez-Biarge M., Cabañas F., et al. (A prognostic neonatal neuroimaging scale for symptomatic congenital cytomegalovirus infection. Neonatology, 2016). 110, 277–285.
Ancora G., Lanari M., Lazzarotto T., et al. (Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. J Pediatr, 2007). 150, 157–161.
Boppana S. B., Fowler K. B., Vaid Y., et al. (Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics, 1997). 99, 409–414.
Cannie M. M., Devlieger R., Leyder M., et al. (Congenital cytomegalovirus infection: contribution and best timing of prenatal MR imaging. Eur Radiol, 2016). 26, 3760–3769.
Capretti M. G., Lanari M., Tani G., et al. (Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection. Brain Dev, 2014). 36, 203–211.
de Vries L. S., Gunardi H., Barth P. G., et al. (The spectrum of cranial ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection. Neuropediatrics, 2004). 35, 113–119.
Fink K. R., Thapa M. M., Ishak G. E., Pruthi S. (Neuroimaging of pediatric central nervous system cytomegalovirus infection. Radiographics, 2010). 30, 1779–1796.
Fowler K. B., Boppana S. B. (Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol, 2006). 35, 226–231.
Fowler K. B., Dahle A. J., Boppana S. B., Pass R. F. (Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr, 1999). 135, 60–64.
Fowler K. B. (Congenital cytomegalovirus infection: audiologic outcome. Clin Infect Dis, 2013). 57, S182–S184.
Goderis J., De Leenheer E., Smets K., Van Hoecke H., Keymeulen A., Dhooge I. (Hearing loss and congenital CMV infection: a systematic review. Pediatrics, 2014). 134, 972–982.
Goderis J., Keymeulen A., Smets K., et al. (Hearing in children with congenital cytomegalovirus infection: Results of a longitudinal study. J Pediatr, 2016). 172, 110–115.
Gravel J. S., Wallace I. F. (Effects of otitis media with effusion on hearing in the first 3 years of life. J Speech Lang Hear Res, 2000). 43, 631–644.
Halwachs-Baumann G. (Congenital Cytomegalovirus Infection—Epidemiology, Diagnosis, Therapy. 2011). Springer.
Kimberlin D. W., Jester P. M., Sánchez P. J., et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med, 2015). 372, 933–943.
Kimberlin D. W., Lin C. Y., Sánchez P. J., et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. (Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr, 2003). 143, 16–25.
Lanari M., Capretti M. G., Lazzarotto T., et al. (Neuroimaging in CMV congenital infected neonates: how and when. Early Hum Dev, 2012). 88, S3–S5.
Luck S. E., Wieringa J. W., Blázquez-Gamero D., et al.; ESPID Congenital CMV Group Meeting, Leipzig 2015. (Congenital cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management. Pediatr Infect Dis J, 2017). 36, 1205–1213.
Madden C., Wiley S., Schleiss M., et al. (Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss. Int J Pediatr Otorhinolaryngol, 2005). 69, 1191–1198.
Madell J. R., Flexer C. (Pediatric Audiology: Diagnosis, Technology, and Management. 2008). Thieme Medical Publishers.
Manara R., Balao L., Baracchini C., et al. (Brain magnetic resonance findings in symptomatic congenital cytomegalovirus infection. Pediatr Radiol, 2011). 41, 962–970.
Morton C. C., Nance W. E. (Newborn hearing screening—a silent revolution. N Engl J Med, 2006). 354, 2151–2164.
Noyola D. E., Demmler G. J., Nelson C. T., et al. (Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr, 2001). 138, 325–331.
Ogawa H., Suzutani T., Baba Y., et al. (Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis, 2007). 195, 782–788.
Oliver S. E., Cloud G. A., Sánchez P. J., et al. (Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol, 2009). 46, S22–S26.
Oosterom N., Nijman J., Gunkel J., et al. (Neuro-imaging findings in infants with congenital cytomegalovirus infection: relation to trimester of infection. Neonatology, 2015). 107, 289–296.
Probst R., Harris F. P. (Transiently evoked and distortion-product otoacoustic emissions. Comparison of results from normally hearing and hearing-impaired human ears. Arch Otolaryngol Head Neck Surg, 1993). 119, 858–860.
Pryor S. P., Demmler G. J., Madeo A. C., et al. (Investigation of the role of congenital cytomegalovirus infection in the etiology of enlarged vestibular aqueducts. Arch Otolaryngol Head Neck Surg, 2005). 131, 388–392.
Rawlinson W. D., Boppana S. B., Fowler K. B., et al. (Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis, 2017). 17, e177–e188.
Rosenthal L. S., Fowler K. B., Boppana S. B., et al. (Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J, 2009). 28, 515–520.
Smets K., De Coen K., Dhooge I., et al. (Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy. Eur J Pediatr, 2006). 165, 885–890.
Stapells D. R., Gravel J. S., Martin B. A. (Thresholds for auditory brain stem responses to tones in notched noise from infants and young children with normal hearing or sensorineural hearing loss. Ear Hear, 1995). 16, 361–371.
van der Knaap M. S., Vermeulen G., Barkhof F., et al. (Pattern of white matter abnormalities at MR imaging: use of polymerase chain reaction testing of Guthrie cards to link pattern with congenital cytomegalovirus infection. Radiology, 2004). 230, 529–536.
van Straaten H. L. (Automated auditory brainstem response in neonatal hearing screening. Acta Paediatr Suppl, 1999). 88, 76–79.